Astal Laboratories Balance Sheet Health
Financial Health criteria checks 3/6
Astal Laboratories has a total shareholder equity of ₹294.7M and total debt of ₹30.7M, which brings its debt-to-equity ratio to 10.4%. Its total assets and total liabilities are ₹605.7M and ₹311.0M respectively.
Key information
10.4%
Debt to equity ratio
₹30.69m
Debt
| Interest coverage ratio | n/a |
| Cash | ₹66.57m |
| Equity | ₹294.71m |
| Total liabilities | ₹311.03m |
| Total assets | ₹605.75m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 512600's short term assets (₹541.7M) exceed its short term liabilities (₹308.4M).
Long Term Liabilities: 512600's short term assets (₹541.7M) exceed its long term liabilities (₹2.6M).
Debt to Equity History and Analysis
Debt Level: 512600 has more cash than its total debt.
Reducing Debt: 512600's debt to equity ratio has increased from 0% to 10.4% over the past 5 years.
Debt Coverage: 512600's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 512600's interest payments on its debt are well covered by EBIT.